Terms: = Liver cancer AND ALDH2, ALDHI, 217, ENSG00000111275, ALDH-E2, P05091, MGC1806, ALDM AND Prognosis
69 results:
1. Transcatheter arterial chemoembolisation combined with lenvatinib and cabozantinib in the treatment of advanced hepatocellular carcinoma.
Liu H; Gan XM; Sun JM; Yang Q; Zhang DZ; Zuo YQ; Liu FL; Li B; Tan QL; Zhang J
Int Immunopharmacol; 2024 Mar; 130():111510. PubMed ID: 38422766
[TBL] [Abstract] [Full Text] [Related]
2. Clinicopathological, metastatic and prognostic features of stage IV esophageal adenocarcinoma versus squamous cell carcinoma: a SEER database analysis.
Pan L; Zhang Y; Gao Y; Qiu J
Chin Clin Oncol; 2024 Feb; 13(1):2. PubMed ID: 38372056
[TBL] [Abstract] [Full Text] [Related]
3. Construction and validation of the predictive model for gallbladder cancer liver metastasis patients: a SEER-based study.
Zhang W; Chen Z; Sa B
Eur J Gastroenterol Hepatol; 2024 Jan; 36(1):129-134. PubMed ID: 37994618
[TBL] [Abstract] [Full Text] [Related]
4. Development of tryptophan metabolism patterns to predict prognosis and immunotherapeutic responses in hepatocellular carcinoma.
Long G; Wang D; Tang J; Tang W
Aging (Albany NY); 2023 Aug; 15(15):7593-7615. PubMed ID: 37540213
[TBL] [Abstract] [Full Text] [Related]
5. Integrated exome sequencing and microarray analyses detected genetic defects and underlying pathways of hepatocellular carcinoma.
Chong ML; Knight J; Peng G; Ji W; Chai H; Lu Y; Wu S; Li P; Hu Q
Cancer Genet; 2023 Aug; 276-277():30-35. PubMed ID: 37418972
[TBL] [Abstract] [Full Text] [Related]
6. Analysis of the prognosis Prediction Ability of a Necroptosis-Related Gene Signature and its Relationship With the Hepatocellular Carcinoma Immune Microenvironment Using Bioinformatics Analysis and Experimental Validation.
Guan R; Mei J; Guo R
Technol Cancer Res Treat; 2023; 22():15330338231182208. PubMed ID: 37335078
[No Abstract] [Full Text] [Related]
7. Macrophage morphology and distribution are strong predictors of prognosis in resected colorectal liver metastases: results from an external retrospective observational study.
Costa G; Sposito C; Soldani C; Polidoro MA; Franceschini B; Marchesi F; Nasir FD; Virdis M; Vingiani A; Leo A; Di Tommaso L; Kotha S; Mantovani A; Mazzaferro V; Donadon M; Torzilli G
Int J Surg; 2023 May; 109(5):1311-1317. PubMed ID: 37037585
[TBL] [Abstract] [Full Text] [Related]
8. Nutritional Status Is Associated with prognosis in Patients with Advanced Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab.
Tada T; Kumada T; Hiraoka A; Kariyama K; Tani J; Hirooka M; Takaguchi K; Atsukawa M; Fukunishi S; Itobayashi E; Tsuji K; Tajiri K; Ochi H; Ishikawa T; Yasuda S; Ogawa C; Toyoda H; Hatanaka T; Nishimura T; Kakizaki S; Kawata K; Shimada N; Tada F; Nouso K; Tsutsui A; Ohama H; Morishita A; Nagano T; Itokawa N; Okubo T; Arai T; Kosaka H; Imai M; Naganuma A; Nakamura S; Koizumi Y; Matono T; Kaibori M; Iijima H; Hiasa Y; ;
Oncology; 2023; 101(4):270-282. PubMed ID: 36455517
[TBL] [Abstract] [Full Text] [Related]
9. Effects of Gene Polymorphisms, Metabolic Activity, and Content of Alcohol Dehydrogenase and Acetaldehyde Dehydrogenases on prognosis of Hepatocellular Carcinoma Patients.
Gao N; Chen J; Qi B; Zhao T; Guo Y; Fang Y; Han Z; Qiao HL
Turk J Gastroenterol; 2022 Jul; 33(7):606-614. PubMed ID: 35879918
[TBL] [Abstract] [Full Text] [Related]
10. Identification of a Necroptosis-Related Prognostic Signature and Associated Regulatory Axis in liver Hepatocellular Carcinoma.
He A; Huang Z; Wang J; Lu H; Zhang R; Wu L; Feng Q
Dis Markers; 2022; 2022():3968303. PubMed ID: 35855852
[TBL] [Abstract] [Full Text] [Related]
11. Proteogenomic characterization of cholangiocarcinoma.
Deng M; Ran P; Chen L; Wang Y; Yu Z; Cai K; Feng J; Qin Z; Yin Y; Tan S; Liu Y; Xu C; Shi G; Ji Y; Zhao JY; Zhou J; Fan J; Hou Y; Ding C
Hepatology; 2023 Feb; 77(2):411-429. PubMed ID: 35716043
[TBL] [Abstract] [Full Text] [Related]
12. Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis: HCC and Steatosis or Steatohepatitis.
Petrelli F; Manara M; Colombo S; De Santi G; Ghidini M; Mariani M; Iaculli A; Rausa E; Rampulla V; Arru M; Viti M; Lonati V; Ghidini A; Luciani A; Facciorusso A
Neoplasia; 2022 Aug; 30():100809. PubMed ID: 35636146
[TBL] [Abstract] [Full Text] [Related]
13. Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Wang J; Zhou C; Yao W; Wang Q; Min X; Chen G; Xu X; Li X; Xu F; Fang Y; Yang R; Yu G; Gong Y; Zhao J; Fan Y; Liu Q; Cao L; Yao Y; Liu Y; Li X; Wu J; He Z; Lu K; Jiang L; Hu C; Zhao W; Zhang B; Shi W; Zhang X; Cheng Y;
Lancet Oncol; 2022 Jun; 23(6):739-747. PubMed ID: 35576956
[TBL] [Abstract] [Full Text] [Related]
14. Comprehensive analysis to identify noncoding RNAs mediated upregulation of maternal embryonic leucine zipper kinase (MELK) correlated with poor prognosis in hepatocellular carcinoma.
Guo Z; Zhu Z
Aging (Albany NY); 2022 May; 14(9):3973-3988. PubMed ID: 35511171
[TBL] [Abstract] [Full Text] [Related]
15. The circROBO1/KLF5/FUS feedback loop regulates the liver metastasis of breast cancer by inhibiting the selective autophagy of afadin.
Wang Z; Yang L; Wu P; Li X; Tang Y; Ou X; Zhang Y; Xiao X; Wang J; Tang H
Mol Cancer; 2022 Jan; 21(1):29. PubMed ID: 35073911
[TBL] [Abstract] [Full Text] [Related]
16. [Comparison of clinical characteristics between sporadic gastrinoma and multiple endocrine neoplasia type 1-related gastrinoma].
Guo Y; Chen LH; Liu M; Zhang YX; Zhang N; Chen J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Oct; 24(10):875-882. PubMed ID: 34674462
[No Abstract] [Full Text] [Related]
17. Hepatocellular carcinoma in Senegal: epidemiological, clinical and etiological aspects about 229 cases at
Diallo I; Ndiaye B; Touré M; Sow A; Mbengue A; Diawara PS; Gning SB; Mbaye PS; Fall F; Mbengue M
Pan Afr Med J; 2021; 38():99. PubMed ID: 33889265
[TBL] [Abstract] [Full Text] [Related]
18. Increasing tumor budding in cholangiocarcinoma is associated with decreased disease-specific survival.
Agostini-Vulaj D; Cates JMM; Bratton LE; Gonzalez RS
Hum Pathol; 2021 May; 111():75-83. PubMed ID: 33727168
[TBL] [Abstract] [Full Text] [Related]
19. SUMO-Activating Enzyme Subunit 1 (SAE1) Is a Promising Diagnostic cancer Metabolism Biomarker of Hepatocellular Carcinoma.
Ong JR; Bamodu OA; Khang NV; Lin YK; Yeh CT; Lee WH; Cherng YG
Cells; 2021 Jan; 10(1):. PubMed ID: 33477333
[TBL] [Abstract] [Full Text] [Related]
20. [Aldehyde dehydrogenase with hepatocellular carcinoma].
Wang WJ; Gao YH
Zhonghua Gan Zang Bing Za Zhi; 2020 Jun; 28(6):475-478. PubMed ID: 32660174
[TBL] [Abstract] [Full Text] [Related]
[Next]
